<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02598271</url>
  </required_header>
  <id_info>
    <org_study_id>1223/2015</org_study_id>
    <nct_id>NCT02598271</nct_id>
  </id_info>
  <brief_title>Influence of Elevated Baseline Serum Creatinine and Body Composition on Acute Kidney Injury in Cardiac Surgery</brief_title>
  <acronym>InCreAS</acronym>
  <official_title>Influence of Elevated Baseline Serum Creatinine and Body Composition on Acute Kidney Injury in Cardiac Surgery - The InCreAS Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute kidney injury (AKI) is an infrequent but major and well - recognized complication of
      cardiac surgery. Recent studies demonstrated that even minimal increases in serum creatinine
      are associated with a rising risk of mortality, hospital length of stay, and cost.
      Furthermore a cut-off for baseline serum creatinine and its influence on mortality after
      cardiac surgery has been shown.

      In this study the investigators want to test if increased bSCr is influenced by body
      composition. Further the investigators want to determine if the incidence of AKI is different
      in patients below or above the estimated cut-off. Therefore the investigators want to perform
      a prospective cohort analysis and will take several other body composition and nutrition
      parameters to test their influence on the predictive power of bSCr. Furthermore the
      investigators want to evaluate several novel biomarkers for AKI on their predictive effect in
      cardiac surgical patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Acute kidney injury (AKI) is an infrequent but major and well - recognized complication of
      cardiac surgery (1, 2). Its incidence ranges from 1 to 30% (3). Numerous pre-, intra-, and
      postoperative factors have been associated with the development of AKI after cardiac surgery
      (3-19). Most commonly used definitions are the absolute serum creatinine level, its change
      within one week and/or the need for dialysis in previously undialysed patients (1, 3-5, 9-11,
      19-25). In patients who are older, more obese with Type 2 diabetes and hypertension, there is
      increasing interest in the effects of chronic kidney disease on the cardiovascular system
      (26). Recent studies demonstrated that even minimal increases in serum creatinine are
      associated with a rising risk of mortality, hospital length of stay, and cost (27, 28). The
      Acute Dialysis Quality Initiative Group standardized with their Risk, Injury, Failure, Loss
      of Kidney Function, End-Stage Kidney Disease criteria and their modifications to the Acute
      Kidney Injury Network criteria the definitions of AKI (19, 29, 30). Both criteria need a
      baseline serum creatinine value for estimation (31).

      In a recent published study (32) a cut-off for baseline serum creatinine and its influence on
      mortality after cardiac surgery has been shown. Under the steady-state and stable kidney
      function, SCr is usually produced at a relatively constant rate by the body depending on the
      absolute amount of muscle mass, and is a reliable and cost-effective surrogate marker for
      kidney function (33). SCr is strongly correlated with weight, total body water and
      anthropometrically estimated lean body mass (LBM) (34). Approximately half of LBM is
      comprised of skeletal muscle mass (35). Recent studies suggest that higher muscle mass is
      associated with greater longevity in people with CKD and other chronic disease states (36,
      37). SCr, however, has several limitations, such as variations in concentration related to
      age, sex, muscle mass and is influenced by dietary protein intake. (38) Furthermore AKI
      affects different complex cellular and molecular pathways. Several novel urinary biomarkers
      such as insulin-like growth factor-binding protein 7 (IGFBP7), tissue inhibitor of
      metalloproteinases-2 (TIMP-2) and neutral endopeptidase (NEP) are involved in the early phase
      of cell injury and predict both the development and severity of AKI and renal recovery early
      after cardiac surgery (39-43) In this study the investigators want to test if increased bSCr
      is influenced by body composition. Further the investigators want to determine if the
      incidence of AKI is different in patients below or above the estimated cut-off. Therefore the
      investigators want to perform a prospective cohort analysis and will take several other body
      composition and nutrition parameters to test their influence on the predictive power of bSCr.
      Furthermore the investigators want to evaluate several novel biomarkers for AKI on their
      predictive effect in cardiac surgical patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Influence of body composition on increased baseline serum creatinine</measure>
    <time_frame>7 days</time_frame>
    <description>Body composition will be measured by bioelectrical impedance analysis, body weight, muscle status and nutrition status</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Influence of increased baseline serum creatinine on difference in acute kidney injury after cardiac surgery</measure>
    <time_frame>7 days</time_frame>
    <description>Acute kidney injury will be defined by current KDIGO-Guidelines for acute kidney inujury</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Influence of neutral endopeptidase on levels of acute kidney injury</measure>
    <time_frame>7 days</time_frame>
    <description>Neutral endopeptidase will be measured out of the urine with ELISA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Influence of right ventricular function on acute kidney injury</measure>
    <time_frame>7 days</time_frame>
    <description>Right ventricular function will be assessed by Tricuspid annular plane systolic excursion (TAPSE) measurements</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of ICU stay</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30 days mortality</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume status</measure>
    <time_frame>7 days</time_frame>
    <description>Need of crystalloid, colloid and blood products</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Acute Kidney Injury</condition>
  <arm_group>
    <arm_group_label>Low SCr</arm_group_label>
    <description>Patients with a serum creatinine below or equal to 1.3mg/dL</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High SCr</arm_group_label>
    <description>Patients with a serum creatinine above to 1.3mg/dL</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing an elective cardiac surgical intervention.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective cardiac surgical intervention

        Exclusion Criteria:

          -  Emergency procedures

          -  Heart transplantation

          -  Elective left ventricular assist device (LVAD) implantation o Pulmonary
             thrombendarterectomy

          -  Declined informed consent

          -  Age &lt; 18 years

          -  Pregnant woman

          -  Preoperative renal replacement therapy (RRT)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin H Bernardi, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Divison of Cardiothoracic Anaesthesia and Intensive Care, Medical University of Vienna</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Martin H Bernardi, Dr.</last_name>
    <phone>004314040041090</phone>
    <email>martin.bernardi@meduniwien.ac.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Andrea Lassnigg, Prof. Dr.</last_name>
    <phone>004314040041090</phone>
    <email>andrea.lassnigg@meduniwien.ac.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Divison of Cardiothoracic Anaesthesia and Intensive Care, Medical University of Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin H Bernardi, MD</last_name>
      <phone>00431404004109</phone>
      <email>martin.bernardi@meduniwien.ac.at</email>
    </contact>
    <contact_backup>
      <last_name>Andrea Lassnigg, MD</last_name>
      <phone>00431404004109</phone>
      <email>andrea.lassnigg@meduniwien.ac.at</email>
    </contact_backup>
    <investigator>
      <last_name>Martin H Bernardi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <reference>
    <citation>Ostermann ME, Taube D, Morgan CJ, Evans TW. Acute renal failure following cardiopulmonary bypass: a changing picture. Intensive Care Med. 2000 May;26(5):565-71.</citation>
    <PMID>10923731</PMID>
  </reference>
  <reference>
    <citation>Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med. 1998 Apr;104(4):343-8.</citation>
    <PMID>9576407</PMID>
  </reference>
  <reference>
    <citation>Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med. 1998 Feb 1;128(3):194-203.</citation>
    <PMID>9454527</PMID>
  </reference>
  <reference>
    <citation>Bahar I, Akgul A, Ozatik MA, Vural KM, Demirbag AE, Boran M, Tasdemir O. Acute renal failure following open heart surgery: risk factors and prognosis. Perfusion. 2005 Oct;20(6):317-22.</citation>
    <PMID>16363316</PMID>
  </reference>
  <reference>
    <citation>Janssen DP, Noyez L, van Druten JA, Skotnicki SH, Lacquet LK. Predictors of nephrological morbidity after coronary artery bypass surgery. Cardiovasc Surg. 2002 Jun;10(3):222-7.</citation>
    <PMID>12044429</PMID>
  </reference>
  <reference>
    <citation>Aronson S, Boisvert D, Lapp W. Isolated systolic hypertension is associated with adverse outcomes from coronary artery bypass grafting surgery. Anesth Analg. 2002 May;94(5):1079-84, table of contents.</citation>
    <PMID>11973166</PMID>
  </reference>
  <reference>
    <citation>Aronson S, Fontes ML, Miao Y, Mangano DT; Investigators of the Multicenter Study of Perioperative Ischemia Research Group; Ischemia Research and Education Foundation. Risk index for perioperative renal dysfunction/failure: critical dependence on pulse pressure hypertension. Circulation. 2007 Feb 13;115(6):733-42. Epub 2007 Feb 5.</citation>
    <PMID>17283267</PMID>
  </reference>
  <reference>
    <citation>Mangano DT, Tudor IC, Dietzel C; Multicenter Study of Perioperative Ischemia Research Group; Ischemia Research and Education Foundation. The risk associated with aprotinin in cardiac surgery. N Engl J Med. 2006 Jan 26;354(4):353-65.</citation>
    <PMID>16436767</PMID>
  </reference>
  <reference>
    <citation>Gaudino M, Luciani N, Giungi S, Caradonna E, Nasso G, Schiavello R, Luciani G, Possati G. Different profiles of patients who require dialysis after cardiac surgery. Ann Thorac Surg. 2005 Mar;79(3):825-9; author reply 829-30.</citation>
    <PMID>15734386</PMID>
  </reference>
  <reference>
    <citation>Kincaid EH, Ashburn DA, Hoyle JR, Reichert MG, Hammon JW, Kon ND. Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery? Ann Thorac Surg. 2005 Oct;80(4):1388-93; discussion 1393.</citation>
    <PMID>16181876</PMID>
  </reference>
  <reference>
    <citation>Regner KR, Connolly HM, Schaff HV, Albright RC. Acute renal failure after cardiac surgery for carcinoid heart disease: incidence, risk factors, and prognosis. Am J Kidney Dis. 2005 May;45(5):826-32. Review.</citation>
    <PMID>15861347</PMID>
  </reference>
  <reference>
    <citation>Mehta RH, Bruckman D, Das S, Tsai T, Russman P, Karavite D, Monaghan H, Sonnad S, Shea MJ, Eagle KA, Deeb GM. Implications of increased left ventricular mass index on in-hospital outcomes in patients undergoing aortic valve surgery. J Thorac Cardiovasc Surg. 2001 Nov;122(5):919-28.</citation>
    <PMID>11689797</PMID>
  </reference>
  <reference>
    <citation>Fischer UM, Weissenberger WK, Warters RD, Geissler HJ, Allen SJ, Mehlhorn U. Impact of cardiopulmonary bypass management on postcardiac surgery renal function. Perfusion. 2002 Nov;17(6):401-6.</citation>
    <PMID>12470028</PMID>
  </reference>
  <reference>
    <citation>Aronson S, Dyke CM, Stierer KA, Levy JH, Cheung AT, Lumb PD, Kereiakes DJ, Newman MF. The ECLIPSE trials: comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients. Anesth Analg. 2008 Oct;107(4):1110-21. doi: 10.1213/ane.0b013e31818240db.</citation>
    <PMID>18806012</PMID>
  </reference>
  <reference>
    <citation>Brown JR, Cochran RP, Leavitt BJ, Dacey LJ, Ross CS, MacKenzie TA, Kunzelman KS, Kramer RS, Hernandez F Jr, Helm RE, Westbrook BM, Dunton RF, Malenka DJ, O'Connor GT; Northern New England Cardiovascular Disease Study Group. Multivariable prediction of renal insufficiency developing after cardiac surgery. Circulation. 2007 Sep 11;116(11 Suppl):I139-43.</citation>
    <PMID>17846294</PMID>
  </reference>
  <reference>
    <citation>Arora P, Rajagopalam S, Ranjan R, Kolli H, Singh M, Venuto R, Lohr J. Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery. Clin J Am Soc Nephrol. 2008 Sep;3(5):1266-73. doi: 10.2215/CJN.05271107. Epub 2008 Jul 30.</citation>
    <PMID>18667735</PMID>
  </reference>
  <reference>
    <citation>Maslow AD, Chaudrey A, Bert A, Schwartz C, Singh A. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid. J Cardiothorac Vasc Anesth. 2008 Feb;22(1):6-15. doi: 10.1053/j.jvca.2007.07.017. Epub 2007 Nov 7.</citation>
    <PMID>18249324</PMID>
  </reference>
  <reference>
    <citation>Salis S, Mazzanti VV, Merli G, Salvi L, Tedesco CC, Veglia F, Sisillo E. Cardiopulmonary bypass duration is an independent predictor of morbidity and mortality after cardiac surgery. J Cardiothorac Vasc Anesth. 2008 Dec;22(6):814-22. doi: 10.1053/j.jvca.2008.08.004. Epub 2008 Oct 22.</citation>
    <PMID>18948034</PMID>
  </reference>
  <reference>
    <citation>Weir MR, Aronson S, Avery EG, Pollack CV Jr. Acute kidney injury following cardiac surgery: role of perioperative blood pressure control. Am J Nephrol. 2011;33(5):438-52. doi: 10.1159/000327601. Epub 2011 Apr 21. Review.</citation>
    <PMID>21508632</PMID>
  </reference>
  <reference>
    <citation>Swaminathan M, Shaw AD, Phillips-Bute BG, McGugan-Clark PL, Archer LE, Talbert S, Milano CA, Patel UD, Stafford-Smith M. Trends in acute renal failure associated with coronary artery bypass graft surgery in the United States. Crit Care Med. 2007 Oct;35(10):2286-91.</citation>
    <PMID>17944016</PMID>
  </reference>
  <reference>
    <citation>Bove T, Calabrò MG, Landoni G, Aletti G, Marino G, Crescenzi G, Rosica C, Zangrillo A. The incidence and risk of acute renal failure after cardiac surgery. J Cardiothorac Vasc Anesth. 2004 Aug;18(4):442-5.</citation>
    <PMID>15365924</PMID>
  </reference>
  <reference>
    <citation>Chertow GM, Lazarus JM, Paganini EP, Allgren RL, Lafayette RA, Sayegh MH. Predictors of mortality and the provision of dialysis in patients with acute tubular necrosis. The Auriculin Anaritide Acute Renal Failure Study Group. J Am Soc Nephrol. 1998 Apr;9(4):692-8.</citation>
    <PMID>9555672</PMID>
  </reference>
  <reference>
    <citation>Leacche M, Rawn JD, Mihaljevic T, Lin J, Karavas AN, Paul S, Byrne JG. Outcomes in patients with normal serum creatinine and with artificial renal support for acute renal failure developing after coronary artery bypass grafting. Am J Cardiol. 2004 Feb 1;93(3):353-6.</citation>
    <PMID>14759390</PMID>
  </reference>
  <reference>
    <citation>Thakar CV, Worley S, Arrigain S, Yared JP, Paganini EP. Influence of renal dysfunction on mortality after cardiac surgery: modifying effect of preoperative renal function. Kidney Int. 2005 Mar;67(3):1112-9.</citation>
    <PMID>15698452</PMID>
  </reference>
  <reference>
    <citation>Doddakula K, Al-Sarraf N, Gately K, Hughes A, Tolan M, Young V, McGovern E. Predictors of acute renal failure requiring renal replacement therapy post cardiac surgery in patients with preoperatively normal renal function. Interact Cardiovasc Thorac Surg. 2007 Jun;6(3):314-8. Epub 2007 Mar 7.</citation>
    <PMID>17669854</PMID>
  </reference>
  <reference>
    <citation>McCullough PA, Haapio M, Mankad S, Zamperetti N, Massie B, Bellomo R, Berl T, Anker SD, Anand I, Aspromonte N, Bagshaw SM, Bobek I, Cruz DN, Daliento L, Davenport A, Hillege H, House AA, Katz N, Maisel A, Mebazaa A, Palazzuoli A, Ponikowski P, Ronco F, Shaw A, Sheinfeld G, Soni S, Vescovo G, Zanco P, Ronco C, Berl T; Acute Dialysis Quality Initiative (ADQI) Consensus Group. Prevention of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrol Dial Transplant. 2010 Jun;25(6):1777-84. doi: 10.1093/ndt/gfq180. Epub 2010 Apr 6.</citation>
    <PMID>20375030</PMID>
  </reference>
  <reference>
    <citation>Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005 Nov;16(11):3365-70. Epub 2005 Sep 21.</citation>
    <PMID>16177006</PMID>
  </reference>
  <reference>
    <citation>Lassnigg A, Schmidlin D, Mouhieddine M, Bachmann LM, Druml W, Bauer P, Hiesmayr M. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol. 2004 Jun;15(6):1597-605.</citation>
    <PMID>15153571</PMID>
  </reference>
  <reference>
    <citation>Srisawat N, Hoste EE, Kellum JA. Modern classification of acute kidney injury. Blood Purif. 2010;29(3):300-7. doi: 10.1159/000280099. Epub 2010 Feb 3. Review.</citation>
    <PMID>20130395</PMID>
  </reference>
  <reference>
    <citation>Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; Acute Dialysis Quality Initiative workgroup. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004 Aug;8(4):R204-12. Epub 2004 May 24. Review.</citation>
    <PMID>15312219</PMID>
  </reference>
  <reference>
    <citation>Závada J, Hoste E, Cartin-Ceba R, Calzavacca P, Gajic O, Clermont G, Bellomo R, Kellum JA; AKI6 investigators. A comparison of three methods to estimate baseline creatinine for RIFLE classification. Nephrol Dial Transplant. 2010 Dec;25(12):3911-8. doi: 10.1093/ndt/gfp766. Epub 2010 Jan 25.</citation>
    <PMID>20100732</PMID>
  </reference>
  <reference>
    <citation>Bernardi MH, Schmidlin D, Schiferer A, Ristl R, Neugebauer T, Hiesmayr M, Druml W, Lassnigg A. Impact of preoperative serum creatinine on short- and long-term mortality after cardiac surgery: a cohort study. Br J Anaesth. 2015 Jan;114(1):53-62. doi: 10.1093/bja/aeu316. Epub 2014 Sep 19.</citation>
    <PMID>25240162</PMID>
  </reference>
  <reference>
    <citation>Heymsfield SB, Arteaga C, McManus C, Smith J, Moffitt S. Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method. Am J Clin Nutr. 1983 Mar;37(3):478-94.</citation>
    <PMID>6829490</PMID>
  </reference>
  <reference>
    <citation>Schutte JE, Longhurst JC, Gaffney FA, Bastian BC, Blomqvist CG. Total plasma creatinine: an accurate measure of total striated muscle mass. J Appl Physiol Respir Environ Exerc Physiol. 1981 Sep;51(3):762-6.</citation>
    <PMID>7327978</PMID>
  </reference>
  <reference>
    <citation>Lee RC, Wang Z, Heo M, Ross R, Janssen I, Heymsfield SB. Total-body skeletal muscle mass: development and cross-validation of anthropometric prediction models. Am J Clin Nutr. 2000 Sep;72(3):796-803. Erratum in: Am J Clin Nutr 2001 May;73(5):995.</citation>
    <PMID>10966902</PMID>
  </reference>
  <reference>
    <citation>von Herrath M, Holzer H. Oxidative inactivation of yeast fructose-1,6-bisphosphatase. Prog Clin Biol Res. 1985;180:329-40.</citation>
    <PMID>2994088</PMID>
  </reference>
  <reference>
    <citation>Solntseva EI, Borisova OV. [Imidazole causes long-term elevation of evoked postsynaptic potential and potential-dependent calcium current in molluskan neurons]. Dokl Akad Nauk SSSR. 1988;300(3):760-3. Russian.</citation>
    <PMID>2844485</PMID>
  </reference>
  <reference>
    <citation>Patel SS, Molnar MZ, Tayek JA, Ix JH, Noori N, Benner D, Heymsfield S, Kopple JD, Kovesdy CP, Kalantar-Zadeh K. Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature. J Cachexia Sarcopenia Muscle. 2013 Mar;4(1):19-29. doi: 10.1007/s13539-012-0079-1. Epub 2012 Jul 10.</citation>
    <PMID>22777757</PMID>
  </reference>
  <reference>
    <citation>Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol. 2006 Jun;17(6):1503-20. Epub 2006 May 17. Review.</citation>
    <PMID>16707563</PMID>
  </reference>
  <reference>
    <citation>Rodier F, Campisi J, Bhaumik D. Two faces of p53: aging and tumor suppression. Nucleic Acids Res. 2007;35(22):7475-84. Epub 2007 Oct 16. Review.</citation>
    <PMID>17942417</PMID>
  </reference>
  <reference>
    <citation>Boonstra J, Post JA. Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene. 2004 Aug 4;337:1-13. Review.</citation>
    <PMID>15276197</PMID>
  </reference>
  <reference>
    <citation>Meersch M, Schmidt C, Van Aken H, Martens S, Rossaint J, Singbartl K, Görlich D, Kellum JA, Zarbock A. Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery. PLoS One. 2014 Mar 27;9(3):e93460. doi: 10.1371/journal.pone.0093460. eCollection 2014.</citation>
    <PMID>24675717</PMID>
  </reference>
  <reference>
    <citation>Truong LD, Shen SS. Immunohistochemical diagnosis of renal neoplasms. Arch Pathol Lab Med. 2011 Jan;135(1):92-109. doi: 10.1043/2010-0478-RAR.1. Review.</citation>
    <PMID>21204715</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 1, 2015</study_first_submitted>
  <study_first_submitted_qc>November 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 5, 2015</study_first_posted>
  <last_update_submitted>February 16, 2018</last_update_submitted>
  <last_update_submitted_qc>February 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Dr. Martin Bernardi</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>Acute Kidney Injury</keyword>
  <keyword>Cardiac Surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

